Home

Gujarat Themis Biosyn Limited

NSE: GUJTHEM

₹413.05
-1.64%
EOD snapshot

About Gujarat Themis Biosyn Limited

Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India and Japan. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease; Rifamycin-O for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy; and Lovastatin. The company was incorporated in 1981 and is based in Mumbai, India.

Healthcare · Drug Manufacturers - Specialty & Generic

Full scanner analysis & price chartMembers

Results

No scheduled results found for GUJTHEM.

Historical quarterly results aren't available in the current data feed.

Corporate Actions

No recent corporate actions for GUJTHEM.

Latest News · Gujarat Themis Biosyn Limited

Loading news…

More in Healthcare

All companies, by sector

Company overview assembled from NSE results / corporate-action feeds and market news. Not investment advice.